Studies suggest that cannabinoids have a wide range of benefits ranging from treating rare forms of epilepsy to reducing anxiety (1). However, cannabinoids are considered to have low oral bioavailability, with only 4%-12% being absorbed in the gastrointestinal tract and reaching the bloodstream. Given this, the need for an effective drug delivery system is paramount to increasing the bioavailability of cannabinoids. O2W is a water-solubilizing and potency enhancing drug delivery system designed to substantially increase the bioavailability of poorly bioavailable compounds, such as cannabinoids. O2W does not alter the cannabinoids chemically but instead acts as a vehicle to encapsulate the active ingredient and deliver it to its intended destination. Pamplona, F. A., da Silva, L. R. & Coan, A. C. Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis. Front. Neurol. 0, 759 (2018).